Development of CFTR structure

Frontiers in Pharmacology

Volumn 3 SEP, Issue , 2012, Pages

  Patrick, Anna E ^a   Thomas, Philip J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ABC transporter; CFTR; Cystic fibrosis; Membrane protein structure; Multidomain protein folding

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; CALNEXIN; CHAPERONE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DERLIN; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 90; MEMBRANE PROTEIN; PROTEIN BAP31; PROTEIN CHIP; PROTEIN NBD1; PROTEIN RMA1; UNCLASSIFIED DRUG;

ARTICLE; FOURTH INTRACELLULAR LOOP; HUMAN; MUTANT; NONHUMAN; NUCLEOTIDE BINDING DOMAIN; NUCLEOTIDE BINDING SITE; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SECOND TRANSMEMBRANE DOMAIN; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 84867113276     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00162     Document Type: Article

References (127)

1. Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., Moss, R. B., Pilewski, J. M., Rubenstein, R. C., Uluer, A. Z., Aitken, M. L., Freedman, S. D., Rose, L. M., Mayer-Hamblett, N., Dong, Q., Zha, J., Stone, A. J., Olson, E. R., Ordonez, C. L., Campbell, P. W., Ashlock, M. A., and Ramsey, B. W. (2010). Effect of VX-770 in persons with cystic fibrosis and the G551DCFTR mutation. N. Engl. J. Med. 363, 1991-2003.
2. Aleksandrov, A. A., Aleksandrov, L. A., and Riordan, J. R. (2007). CFTR (ABCC7) is a hydrolyzable-ligandgated channel. Pflugers Arch. 453, 693-702.
3. Aleksandrov, A. A., Kota, P., Aleksandrov, L. A., He, L., Jensen, T., Cui, L., Gentzsch, M., Dokholyan, N. V., and Riordan, J. R. (2010). Regulatory insertion removal restores maturation, stability, and function of deltaF508 CFTR. J. Mol. Biol. 401, 194-210.
4. Aleksandrov, L., Aleksandrov, A. A., Chang, X. B., and Riordan, J. R. (2002). The first nucleotide binding domain of cystic fibrosis transmembrane conductance regulator is a site of stable nucleotide interaction, whereas the second is a site of rapid turnover. J. Biol. Chem. 277, 15419-15425.
5. Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., and Chang, G. (2009). Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding. Science 323, 1718-1722.
6. Baker, J. M., Hudson, R. P., Kanelis, V., Choy, W. Y., Thibodeau, P. H., Thomas, P. J., and Forman-Kay, J. D. (2007). CFTR regulatory region interacts with NBD1 predominantly via multiple transient helices. Nat. Struct. Mol. Biol. 14, 738-745.
7. Basso, C., Vergani, P., Nairn, A. C., and Gadsby, D. C. (2003). Prolonged nonhydrolytic interaction of nucleotide with CFTR's NH2terminal nucleotide binding domain and its role in channel gating. J. Gen. Physiol. 122, 333-348.
8. Biemans-Oldehinkel, E., Doeven, M. K., and Poolman, B. (2006). ABC transporter architecture and regulatory roles of accessory domains. FEBS Lett. 580, 1023-1035.
9. Borst, P., and Elferink, R. O. (2002). Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71, 537-592.
10. Cebotaru, L., Vij, N., Ciobanu, I., Wright, J., Flotte, T., and Guggino,W. B. (2008). Cystic fibrosis transmembrane regulator missing the first four transmembrane segments increases wild type and deltaF508 processing. J. Biol. Chem. 283, 21926-21933.
11. Chan, K. W., Csanady, L., Seto-Young, D., Nairn, A. C., and Gadsby, D. C. (2000). Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain. J. Gen. Physiol. 116, 163-180.
12. Chang, X. B., Mengos, A., Hou, Y. X., Cui, L., Jensen, T. J., Aleksandrov, A., Riordan, J. R., and Gentzsch, M. (2008). Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator. J. Cell. Sci. 121, 2814-2823.
13. Chappe, V., Irvine, T., Liao, J., Evagelidis, A., and Hanrahan, J. W. (2005).
14. Phosphorylation of CFTR by PKA promotes binding of the regulatory domain. EMBO J. 24, 2730-2740.
15. Chen, E. Y., Bartlett, M. C., Loo, T. W., and Clarke, D. M. (2004). The deltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 279, 39620-39627.
16. Chen, J., Sharma, S., Quiocho, F. A., and Davidson, A. L. (2001). Trapping the transition state of an ATPbinding cassette transporter: evidence for a concerted mechanism of maltose transport. Proc. Natl. Acad. Sci. U.S.A. 98, 1525-1530.
17. Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'riordan, C. R., and Smith, A. E. (1990). Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834.
18. Cheung, J. C., and Deber, C. M. (2008). Misfolding of the cystic fibrosis transmembrane conductance regulator and disease. Biochemistry 47, 1465-1473.
19. Cormet-Boyaka, E., Jablonsky, M., Naren, A. P., Jackson, P. L., Muccio, D. D., and Kirk, K. L. (2004). Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation. Proc. Natl. Acad. Sci. U.S.A. 101, 8221-8226.
20. Cotten, J. F., Ostedgaard, L. S., Carson, M. R., and Welsh, M. J. (1996). Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 271, 21279-21284.
21. Csanady, L., Chan, K. W., Seto-Young, D., Kopsco, D. C., Nairn, A. C., and Gadsby, D. C. (2000). Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains. J. Gen. Physiol. 116, 477-500.
22. Cui, L., Aleksandrov, L., Chang, X. B., Hou, Y. X., He, L., Hegedus, T., Gentzsch, M., Aleksandrov, A., Balch, W. E., and Riordan, J. R. (2007). Domain interdependence in the biosynthetic assembly of CFTR. J. Mol. Biol. 365, 981-994.
23. Dalemans, W., Barbry, P., Champigny, G., Jallat, S., Dott, K., Dreyer, D., Crystal, R. G., Pavirani, A., Lecocq, J. P., and Lazdunski, M. (1991). Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 354, 526-528.
24. Dawson, R. J., Hollenstein, K., and Locher, K. P. (2007). Uptake or extrusion: crystal structures of full ABC transporters suggest a common mechanism. Mol. Microbiol. 65, 250-257.
25. Dawson, R. J., and Locher, K. P. (2006). Structure of a bacterial multidrug ABC transporter. Nature 443, 180-185.
26. Dawson, R. J., and Locher, K. P. (2007). Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP-PNP. FEBS Lett. 581, 935-938.
27. Dean, M., Rzhetsky, A., and Allikmets, R. (2001). The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11, 1156-1166.
28. DeCarvalho, A. C., Gansheroff, L. J., and Teem, J. L. (2002). Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator delta f508. J. Biol. Chem. 277, 35896-35905.
29. Denning, G. M., Anderson, M. P., Amara, J. F., Marshall, J., Smith, A. E., and Welsh, M. J. (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764.
30. Devidas, S., Yue, H., and Guggino, W. B. (1998). The second half of the cystic fibrosis transmembrane conductance regulator forms a functional chloride channel. J. Biol. Chem. 273, 29373-29380.
31. Di Bartolo, N. D., Hvorup, R. N., Locher, K. P., and Booth, P. J. (2011). In vitro folding and assembly of the Escherichia coli ATP-binding cassette transporter, BtuCD. J. Biol. Chem. 286, 18807-18815.
32. Du, K., and Lukacs, G. L. (2009). Cooperative assembly and misfolding of CFTR domains in vivo. Mol. Biol. Cell 20, 1903-1915.
33. Du, K., Sharma, M., and Lukacs, G. L. (2005). The deltaF508 cystic fibrosis mutation impairs domaindomain interactions and arrests post-translational folding of CFTR. Nat. Struct. Mol. Biol. 12, 17-25.
34. Gadsby, D. C. (2009). Ion channels versus ion pumps: the principal difference, in principle. Nat. Rev. Mol. Cell Biol. 10, 344-352.
35. Gadsby, D. C., Vergani, P., and Csanady, L. (2006). The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440, 477-483.
36. Glozman, R., Okiyoneda, T., Mulvihill, C. M., Rini, J. M., Barriere, H., and Lukacs, G. L. (2009). N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. J. Cell Biol. 184, 847-862.
37. Gottesman, M. M., and Ambudkar, S. V. (2001). Overview: ABC transporters and human disease. J. Bioenerg. Bio- membr. 33, 453-458.
38. Gregory, R. J., Rich, D. P., Cheng, S. H., Souza, D. W., Paul, S., Manavalan, P., Anderson, M. P., Welsh, M. J., and Smith, A. E. (1991). Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol. Cell. Biol. 11, 3886-3893.
39. Grove, D. E., Fan, C. Y., Ren, H. Y., and Cyr, D. M. (2011). The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70 cooperate to facilitate RMA1 E3dependent degradation of nascent CFTRdeltaF508. Mol. Biol. Cell 22, 301-314.
40. Grove, D. E., Rosser, M. F., Ren, H. Y., Naren, A. P., and Cyr, D. M. (2009). Mechanisms for rescue of correctable folding defects in
41. CFTRdelta F508. Mol. Biol. Cell 20, 4059-4069.
42. He, L., Aleksandrov, A. A., Serohijos, A. W., Hegedus, T., Aleksandrov, L. A., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008). Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating. J. Biol. Chem. 283, 26383-26390.
43. Helenius, A., and Aebi, M. (2001). Intracellular functions of N-linked glycans. Science 291, 2364-2369.
44. Hoelen, H., Kleizen, B., Schmidt, A., Richardson, J., Charitou, P., Thomas, P. J., and Braakman, I. (2010). The primary folding defect and rescue of deltaF508 CFTR emerge during translation of the mutant domain. PLoS ONE 5, e15458. doi:10.1371/journal.pone.0015458
45. Hohl, M., Briand, C., Grutter, M. G., and Seeger, M. A. (2012). Crystal structure of a heterodimeric ABC transporter in its inward-facing conformation. Nat. Struct. Mol. Biol. 19, 395-402.
46. Holland, I. B. (2003). ABC Proteins: from Bacteria to Man. Amsterdam, Boston: Academic Press.
47. Hollenstein, K., Frei, D. C., and Locher, K. P. (2007). Structure of an ABC transporter in complex with its binding protein. Nature 446, 213-216.
48. Howard, M., Duvall, M. D., Devor, D. C., Dong, J. Y., Henze, K., and Frizzell, R. A. (1995). Epitope tagging permits cell surface detection of functional CFTR. Am. J. Physiol. 269, C1565-C1576.
49. Jensen, T. J., Loo, M. A., Pind, S., Williams, D. B., Goldberg, A. L., and Riordan, J. R. (1995). Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129-135.
50. Jordan, I. K., Kota, K. C., Cui, G., Thompson, C. H., and McCarty, N. A. (2008). Evolutionary and functional divergence between the cystic fibrosis transmembrane conductance regulator and related ATP-binding cassette transporters. Proc. Natl. Acad. Sci. U.S.A. 105, 18865-18870.
51. Kanelis, V., Hudson, R. P., Thibodeau, P. H., Thomas, P. J., and FormanKay, J. D. (2010). NMR evidence for differential phosphorylationdependent interactions in WT and deltaF508 CFTR. EMBO J. 29, 263-277.
52. Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M. and Tsui, L. C. (1989). Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080.
53. Kerem, E. (2004). Pharmacologic therapy for stop mutations: how much CFTR activity is enough? Curr. Opin. Pulm. Med. 10, 547-552.
54. Khushoo, A., Yang, Z., Johnson, A. E., and Skach, W. R. (2011). Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1. Mol. Cell 41, 682-692.
55. Kleizen, B., Van Vlijmen, T., De Jonge, H. R., and Braakman, I. (2005). Folding of CFTR is predominantly cotranslational. Mol. Cell 20, 277-287.
56. Kramer, G., Ramachandiran, V., and Hardesty, B. (2001). Cotranslational folding-omnia mea mecum porto? Int. J. Biochem. Cell. Biol. 33, 541-553.
57. Lewis, H. A., Buchanan, S. G., Burley, S. K., Conners, K., Dickey, M., Dorwart, M., Fowler, R., Gao, X., Guggino, W. B., Hendrickson, W. A., Hunt, J. F., Kearins, M. C., Lorimer, D., Maloney, P. C., Post, K. W., Rajashankar, K. R., Rutter, M. E., Sauder, J. M., Shriver, S., Thibodeau, P. H., Thomas, P. J., Zhang, M., Zhao, X., and Emtage, S. (2004). Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. EMBO J. 23, 282-293.
58. Lewis, H. A., Wang, C., Zhao, X., Hamuro,Y.,Conners,K.,Kearins,M. C., Lu, F., Sauder, J. M., Molnar, K. S., Coales, S. J., Maloney, P. C., Guggino,W. B.,Wetmore,D. R.,Weber,P. C., and Hunt, J. F. (2010). Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry. J. Mol. Biol. 396, 406-430.
59. Lewis, H. A., Zhao, X.,Wang, C., Sauder, J. M., Rooney, I., Noland, B. W., Lorimer,D.,Kearins,M. C.,Conners, K., Condon, B., Maloney, P. C., Guggino, W. B., Hunt, J. F., and Emtage, S. (2005). Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J. Biol. Chem. 280, 1346-1353.
60. Linsdell, P. (2006). Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. Exp. Physiol. 91, 123-129.
61. Linton, K. J., and Higgins, C. F. (1998). The Escherichia coli ATP-binding cassette (ABC) proteins. Mol. Micro- biol. 28, 5-13.
62. Locher, K. P. (2009). Review. Structure and mechanism of ATP-binding cassette transporters. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 239-245.
63. Locher, K. P., Lee, A. T., and Rees, D. C. (2002). The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 296, 1091-1098.
64. Loo, T. W., Bartlett, M. C., and Clarke, D. M. (2011). Benzbromarone stabilizes deltaF508 CFTR at the cell surface. Biochemistry 50,4393-4395
65. Loo, T. W., and Clarke, D. M. (2008). Mutational analysis of ABC proteins. Arch. Biochem. Biophys. 476, 51-64.
66. Louie, R. J., Pagant, S., Youn, J. Y., Halliday, J. J., Huyer, G., Michaelis, S., and Miller, E. A. (2010). Functional rescue of a misfolded eukaryotic ATP-binding cassette transporter by domain replacement. J. Biol. Chem. 285, 36225-36234.
67. Lukacs, G. L., Chang, X. B., Bear, C., Kartner, N., Mohamed, A., Riordan, J. R., and Grinstein, S. (1993). The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J. Biol. Chem. 268, 21592-21598.
68. Lukacs, G. L., Mohamed, A., Kartner, N., Chang, X. B., Riordan, J. R., and Grinstein, S. (1994). Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13, 6076-6086.
69. Meacham, G. C., Lu, Z., King, S., Sorscher, E., Tousson, A., and Cyr, D. M. (1999). The Hdj-2/Hsc70 chaperone pair facilitates early steps in CFTR biogenesis. EMBO J. 18, 1492-1505.
70. Meacham, G. C., Patterson, C., Zhang, W., Younger, J. M., and Cyr, D. M. (2001). The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol. 3, 100-105.
71. Mendoza, J. L., Schmidt, A., Li, Q., Nuvaga, E., Barrett, T., Bridges, R. J., Feranchak, A. P., Brautigam, C. A., and Thomas, P. J. (2012). Requirements for efficient correction of deltaF508 CFTR revealed by analyses of evolved sequences. Cell 148, 164-174.
72. Mendoza, J. L., and Thomas, P. J. (2007). Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J. Bioenerg. Biomembr. 39, 499-505.
73. Mense, M., Vergani, P., White, D. M., Altberg, G., Nairn, A. C., and Gadsby, D. C. (2006). In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J. 25, 4728-4739.
74. Moody, J. E., Millen, L., Binns, D., Hunt, J. F., and Thomas, P. J. (2002). Cooperative, ATP-dependent association of the nucleotide binding cassettes during the catalytic cycle of ATPbinding cassette transporters. J. Biol. Chem. 277, 21111-21114.
75. Mornon, J. P., Lehn, P., and Callebaut, I. (2008). Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces. Cell. Mol. Life Sci. 65, 2594-2612.
76. Mornon, J. P., Lehn, P., and Callebaut, I. (2009). Molecular models of the open and closed states of the whole human CFTR protein. Cell. Mol. Life Sci. 66, 3469-3486.
77. Muallem, D., and Vergani, P. (2009). Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 247-255.
78. Naren, A. P., Cormet-Boyaka, E., Fu, J., Villain, M., Blalock, J. E., Quick, M. W., and Kirk, K. L. (1999). CFTR chloride channel regulation by an interdomain interaction. Sci- ence 286, 544-548.
79. Nikles, D., and Tampe, R. (2007). Targeted degradation of ABC transporters in health and disease. J. Bioenerg. Biomembr. 39, 489-497.
80. Okiyoneda, T., Barriere, H., Bagdany, M., Rabeh, W. M., Du, K., Hohfeld, J., Young, J. C., and Lukacs, G. L. (2010). Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 329, 805-810.
81. Okiyoneda, T., and Lukacs, G. L. (2007). Cell surface dynamics of CFTR: the ins and outs. Biochim. Biophys. Acta 1773, 476-479.
82. Ostedgaard, L. S., Rich, D. P., Deberg, L. G., and Welsh, M. J. (1997). Association of domains within the cystic fibrosis transmembrane conductance regulator. Biochemistry 36, 1287-1294.
83. Pagant, S., Brovman, E. Y., Halliday, J. J., and Miller, E. A. (2008). Mapping of interdomain interfaces required for the functional architecture of Yor1p, a eukaryotic ATP-binding cassette (ABC) transporter. J. Biol. Chem. 283, 26444-26451.
84. Pagant, S., Halliday, J. J., Kougentakis, C., and Miller, E. A. (2010).
85. Intragenic suppressing mutations correct the folding and intracellular traffic of misfolded mutants of Yor1p, a eukaryotic drug transporter. J. Biol. Chem. 285, 36304-36314.
86. Pagant, S., Kung, L., Dorrington, M., Lee, M. C., and Miller, E. A. (2007). Inhibiting endoplasmic reticulum (ER)-associated degradation of misfolded Yor1p does not permit ER export despite the presence of a diacidic sorting signal. Mol. Biol. Cell 18, 3398-3413.
87. Patrick, A. E., Karamyshev, A. L., Millen, L., and Thomas, P. J. (2011). Alteration of CFTR transmembrane span integration by diseasecausing mutations. Mol. Biol. Cell 22, 4461-4471.
88. Pind, S., Riordan, J. R., and Williams, D. B. (1994). Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269, 12784-12788.
89. Pollet, J. F., Van Geffel, J., Van Stevens, E., Van Geffel, R., Beauwens, R., Bollen, A., and Jacobs, P. (2000). Expression and intracellular processing of chimeric and mutant CFTR molecules. Biochim. Biophys. Acta 1500, 59-69.
90. Qu, B. H., Strickland, E. H., and Thomas, P. J. (1997). Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J. Biol. Chem. 272, 15739-15744.
91. Qu, B. H., and Thomas, P. J. (1996). Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway. J. Biol. Chem. 271, 7261-7264.
92. Rabeh, W. M., Bossard, F., Xu, H., Okiyoneda, T., Bagdany, M., Mulvihill, C. M., Du, K., Di Bernardo, S., Liu, Y., Konermann, L., Roldan, A., and Lukacs, G. L. (2012). Correction of both NBD1 energetics and domain interface is required to restore deltaF508 CFTR folding and function. Cell 148, 150-163.
93. Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Drevinek, P., Griese, M., Mckone, E. F., Wainwright, C. E., Konstan, M. W., Moss, R., Ratjen, F., Sermet-Gaudelus, I., Rowe, S. M., Dong, Q., Rodriguez, S., Yen, K., Ordonez, C., and Elborn, J. S. (2011). A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N. Engl. J. Med. 365, 1663-1672.
94. Rees, D. C., Johnson, E., and Lewinson, O. (2009). ABC transporters:
95. the power to change. Nat. Rev. Mol. Cell Biol. 10, 218-227.
96. Rich, D. P., Gregory, R. J., Anderson, M. P., Manavalan, P., Smith, A. E., and Welsh, M. J. (1991). Effect of deleting the R domain on CFTRgenerated chloride channels. Science 253, 205-207.
97. Riordan, J. R. (2008). CFTR function and prospects for therapy. Annu. Rev. Biochem. 77, 701-726.
98. Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J. L., Drumm, M. L., Iannuzzi, M. C., Collin, F. S., and Tsui, L.-C. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073.
99. Rommens, J. M., Iannuzzi, M. C., Kerem, B., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., Zsiga, M., Buchwald, M., Riordan, J. R., Tsui, L.-C., and Collins, F. S. (1989). Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245, 1059-1065.
100. Rosenberg, M. F., Kamis, A. B., Aleksandrov, L. A., Ford, R. C., and Riordan, J. R. (2004). Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J. Biol. Chem. 279, 39051-39057.
101. Rosenberg, M. F., O'ryan, L. P., Hughes, G.,Zhao,Z.,Aleksandrov,L.A.,Riordan,J. R.,and Ford,R. C. (2011). The cystic fibrosis transmembrane conductance regulator (CFTR): threedimensional structure and localization of a channel gate. J. Biol. Chem. 286, 42647-42654.
102. Rosser, M. F., Grove, D. E., Chen, L., and Cyr, D. M. (2008). Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexin-dependent association of membrane spanning domain (MSD) 1 and MSD2. Mol. Biol. Cell 19, 4570-4579.
103. Seibert, F. S., Linsdell, P., Loo, T. W., Hanrahan, J. W., Clarke, D. M., and Riordan, J. R. (1996). Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J. Biol. Chem. 271, 15139-15145.
104. Serohijos, A. W., Hegedus, T., Aleksandrov, A. A., He, L., Cui, L., Dokholyan, N. V., and Riordan, J. R. (2008). Phenylalanine-508 mediates
105. Sheppard, D. N. (2011). Cystic fibrosis: CFTR correctors to the rescue. Chem. Biol. 18, 145-147.
106. Sheppard, D. N., Ostedgaard, L. S., Rich, D. P., and Welsh, M. J. (1994). The amino-terminal portion of CFTR forms a regulated Cl-channel. Cell 76, 1091-1098.
107. Smith, P. C., Karpowich, N., Millen, L., Moody, J. E., Rosen, J., Thomas, P. J., and Hunt, J. F. (2002). ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol. Cell 10, 139-149.
108. Strickland, E., Qu, B. H., Millen, L., and Thomas, P. J. (1997). The molecular chaperone Hsc70 assists the in vitro folding of the N-terminal nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 272, 25421-25424.
109. Sun, F., Zhang, R., Gong, X., Geng, X., Drain, P. F., and Frizzell, R. A. (2006). Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants. J. Biol. Chem. 281, 36856-36863.
110. Teem, J. L., Berger, H. A., Ostedgaard, L. S., Rich, D. P., Tsui, L. C., and Welsh, M. J. (1993). Identification of revertants for the cystic fibrosis delta F508 mutation using STE6CFTR chimeras in yeast. Cell 73, 335-346.
111. Thibodeau, P. H., Brautigam, C. A., Machius, M., and Thomas, P. J. (2005). Side chain and backbone contributions of Phe508 to CFTR folding. Nat. Struct. Mol. Biol. 12, 10-16.
112. Thibodeau, P. H., Richardson, J. M. III, Wang, W., Millen, L., Watson, J., Mendoza, J. L., Du, K., Fischman, S., Senderowitz, H., Lukacs, G. L., Kirk, K., and Thomas, P. J. (2010). The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J. Biol. Chem. 285, 35825-35835.
113. Thomas, P. J., Shenbagamurthi, P., Sondek, J., Hullihen, J. M., and Pedersen, P. L. (1992). The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. J. Biol. Chem. 267, 5727-5730.
114. Van Goor, F., Hadida, S., Grootenhuis, P. D., Burton, B., Cao, D., Neuberger, T., Turnbull, A., Singh, A., Joubran, J., Hazlewood, A., Zhou, J., McCartney, J., Arumugam, V., Decker, C., Yang, J., Young, C., Olson, E. R., Wine, J. J., Frizzell, R. A., Ashlock, M., and Negulescu, P. (2009). Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX770. Proc. Natl. Acad. Sci. U.S.A. 106, 18825-18830.
115. Vergani, P., Lockless, S. W., Nairn, A. C., and Gadsby, D. C. (2005). CFTR channel opening by ATP-driven tight dimerization of its nucleotidebinding domains. Nature 433, 876-880.
116. Wang, B., Heath-Engel, H., Zhang, D., Nguyen, N., Thomas, D. Y., Hanrahan, J. W., and Shore, G. C. (2008). BAP31 interacts with Sec61 translocons and promotes retrotranslocation of CFTRdeltaF508 via the derlin-1 complex. Cell 133, 1080-1092.
117. Wang, X., Venable, J., Lapointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., Gurkan, C., Kellner, W., Matteson J., Plutner, H., Riordan, J. R., Kelly, J. W., Yates, J. R. III, and Balch, W. E. (2006). Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803-815.
118. Ward, A., Reyes, C. L., Yu, J., Roth, C. B., and Chang, G. (2007). Flexibility in the ABC transporter MsbA: alternating access with a twist. Proc. Natl. Acad. Sci. U.S.A. 104, 19005-19010.
119. Ward, C. L., Omura, S., and Kopito, R. R. (1995). Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127.
120. Welsh, M. J., and Smith, A. E. (1993). Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73, 1251-1254.
121. Woolhead, C. A., McCormick, P. J., and Johnson, A. E. (2004). Nascent membrane and secretory proteins differ in FRET-detected folding far inside the ribosome and in their exposure to ribosomal proteins. Cell 116, 725-736.
122. Xiong, X., Bragin, A., Widdicombe, J. H., Cohn, J., and Skach, W. R. (1997). Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator. J. Clin. Invest. 100, 1079-1088.
123. Younger, J. M., Chen, L., Ren, H. Y., Rosser, M. F., Turnbull, E. L., Fan, C. Y., Patterson, C., and Cyr, D. M. (2006). Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126, 571-582.
124. Zhang, F., Kartner, N., and Lukacs, G. L. (1998). Limited proteolysis as a probe for arrested conformational maturation of delta F508 CFTR. Nat. Struct. Biol. 5, 180-183.
125. Zhang, L., Aleksandrov, L. A., Riordan, J. R., and Ford, R. C. (2011). Domain location within the cystic fibrosis transmembrane conductance regulator protein investigated by electron microscopy and gold labelling. Biochim. Biophys. Acta 1808, 399-404.
126. Zhang, L., Aleksandrov, L. A., Zhao, Z., Birtley, J. R., Riordan, J. R., and Ford, R. C. (2009). Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. J. Struct. Biol. 167, 242-251.
127. Zielenski, J., and Tsui, L. C. (1995). Cystic fibrosis: genotypic and phenotypic variations. Annu. Rev. Genet. 29, 777-807.